Given that novel CGRP and CGRP receptor blockers are now used clinically for migraine treatment, and the lack of direct evidence for a physiologic role of αCGRP in bone healing, our study aimed to evaluate the role of αCGRP in bone regeneration to characterize fracture healing in mice with global αCGRP inactivation. Here, CALCA is linked to migraine disorder.